Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Akin

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
Blood|August 22, 2015
Cladribine for mastocytosis: benefits and risksCem Akin
Hematology. American Society of Hematology. Education Program|December 9, 2022
How to evaluate the patient with a suspected mast cell disorder and how/when to manage symptomsCem Akin
Immunology and Allergy Clinics of North America|April 6, 2015
Mast cell activation syndromes presenting as anaphylaxisCem Akin
The Journal of Allergy and Clinical Immunology. in Practice|May 10, 2014
Mast cell activation disordersCem Akin
Acta Haematologica|July 5, 2005
Clonality and molecular pathogenesis of mastocytosisCem Akin
The Journal of Molecular Diagnostics : JMD|August 26, 2006
Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular PathologyCem Akin
Immunology and Allergy Clinics of North America|September 27, 2023
Tyrosine Kinase Inhibitors in Non-advanced Systemic MastocytosisCem Akin
The Journal of Allergy and Clinical Immunology|November 14, 2024
Omalizumab for mast cell disordersCem Akin
Immunology and Allergy Clinics of North America|September 27, 2023
Mastocytosis: Aiming for the Right TargetsCem Akin
Leukemia Research|July 16, 2003
Multilineage hematopoietic involvement in systemic mastocytosisCem Akin
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
Blood|August 22, 2015
Cladribine for mastocytosis: benefits and risksCem Akin
Hematology. American Society of Hematology. Education Program|December 9, 2022
How to evaluate the patient with a suspected mast cell disorder and how/when to manage symptomsCem Akin
Immunology and Allergy Clinics of North America|April 6, 2015
Mast cell activation syndromes presenting as anaphylaxisCem Akin
The Journal of Allergy and Clinical Immunology. in Practice|May 10, 2014
Mast cell activation disordersCem Akin
Acta Haematologica|July 5, 2005
Clonality and molecular pathogenesis of mastocytosisCem Akin
The Journal of Molecular Diagnostics : JMD|August 26, 2006
Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular PathologyCem Akin
Immunology and Allergy Clinics of North America|September 27, 2023
Tyrosine Kinase Inhibitors in Non-advanced Systemic MastocytosisCem Akin
The Journal of Allergy and Clinical Immunology|November 14, 2024
Omalizumab for mast cell disordersCem Akin
Immunology and Allergy Clinics of North America|September 27, 2023
Mastocytosis: Aiming for the Right TargetsCem Akin
Leukemia Research|July 16, 2003
Multilineage hematopoietic involvement in systemic mastocytosisCem Akin
Pageof 21